Skip to main content
. 2021 Jul 25;13(8):1448. doi: 10.3390/v13081448

Figure 1.

Figure 1

Frequencies of regulatory T cells in HCV-infected (left column) and HCV/HIV-coinfected (right column) patients in the course of anti-viral therapy. Data presenting the effects of therapy and differences between studied groups in the course of treatment in relation to healthy control subjects. Treg-related parameters included: Foxp3-positive cells within CD4+ (a) and CD4+CD25+CD127 lymphocytes (b), frequency of CD25+CD127Foxp3+ (c) and CD25+CD127- (d) in pool of CD4+ T cells.